Skip to content
DraconiticResearch
Search Sources API
201,818 studies31 sourcesUpdated 59 min ago
Peer-reviewedCC BY 4.0Frontiers in Immunology

Immunological and metabolic profiles associated with active Giardia intestinalis infection in adults with metabolic disorders: an exploratory analysis

5 affiliations
  1. 1Department of Nucleic Acid Biochemistry, Medical University of Lodz
  2. 2AllerGen Center of Personalized Medicine
  3. 3Department of Immunoparasitology and Molecular Allergology, Jan Dlugosz University
  4. 4Diabetology and Internal Medicine Department, Provincial Hospital in Sieradz
  5. 5Department of Immunology and Allergy, Medical University of Lodz

Abstract

Background: Giardiasis may present with nonspecific gastrointestinal symptoms, and conventional diagnostic approaches may not fully capture host-response differences in clinically complex patients. This study characterized immunological and metabolic measurements associated with active G. intestinalis infection in adults with metabolic disorders and examined their differences according to infection status and treatment stage. An exploratory secondary analysis assessed whether selected variables could jointly discriminate infection status.

Methods: In this prospective observational study, 84 adults with metabolic disorders aged 40–65 years were included at baseline and classified according to G. intestinalis infection status; 80 participants were included in the final analytical sample. Anti- Giardia IgM and IgG, multiplex cytokines, chemokines and growth factors, anthropometric measures, and metabolic parameters were assessed. Differences according to infection status and treatment stage were examined using non-parametric tests, Spearman correlations, and logistic regression. Selected variables were subsequently evaluated using multivariable logistic regression and receiver operating characteristic (ROC) analysis. Internal model performance was assessed using bootstrap resampling and stratified 10-fold cross-validation within the study cohort.

Results: Active G. intestinalis infection was associated with lower glucose, BMI, and HOMA-IR values and with differences in selected inflammatory mediators. IgM, IL-12p40, IL-8, RANTES, and IL-2R were among the variables associated with infection status in regression analyses. An exploratory integrated model including glucose, BMI, IgM, RANTES, IL-12p40, and IL-2R showed an apparent AUC of 0.953. Internal performance assessment using bootstrap resampling and stratified 10-fold cross-validation yielded similar estimates within the study cohort. Differences in apparent AUC between the integrated, immunological, and metabolic models were interpreted descriptively because no formal statistical comparison of ROC curves was performed.

Conclusions: In this study population, active G. intestinalis infection was associated with distinct immunological and metabolic patterns. The exploratory multivariable analysis identified a combination of immunological and metabolic variables with high apparent discriminatory performance within the present cohort. These findings are hypothesis-generating, and the identified predictor combination requires evaluation in substantially larger independent cohorts with prospective model development and external validation before its predictive or clinical utility can be determined.

Related

  1. Single-cell transcriptomics of Encephalitozoon intestinalis infection in Caco-2 and Vero cells
    N. V. Antao, G. Bhabha, D. C. Ekiert
    bioRxivPreprintAll rights reservedFull textMicrobiologybioRxiv
  2. Campylobacter jejuni Infection Is Associated With Cell-Cycle, Redox, and Metabolic Remodeling of Human Intestinal Epithelial Cells at Single-Cell Resolution
    A. Gao, V. Newhart, S. Kassis +2
    bioRxivPreprintAll rights reservedFull textMicrobiologybioRxiv
  3. The Immunological Purity Theory: a testable framework linking peri-menstrual endometrial immune transition to receptivity and implantation, with exploratory implications for neurodevelopment
    Budor H. Saigh
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0Full textImmunologyCrossrefPMC
  4. Interferon lambda drives immunological maturation in the infant lung and protects against lethal Bordetella pertussis infection
    D. Johnson, N. H. Carbonetti
    bioRxivPreprintCC BY-NC-NDFull textImmunologybioRxiv
  5. Immunological alterations and associated diseases in mandrills (Mandrillus sphinx) naturally co-infected with SIV and STLV
    Sandrine Souquière, Maria Makuwa, Bettina Sallé +4
    VirologyPeer-reviewedLicence not statedFull text6 citedMicrobiologyHAL
BibTeX
@article{klimczak2026immunological,
  title = {{Immunological and metabolic profiles associated with active Giardia intestinalis infection in adults with metabolic disorders: an exploratory analysis}},
  author = {Sylwia Klimczak and Kacper Packi and Alicja Rudek and Sylwia Wenclewska and Marcin Kurowski and Agnieszka Śliwińska},
  journal = {Frontiers in Immunology},
  year = {2026},
  month = oct,
  doi = {10.3389/fimmu.2026.1936690},
  url = {https://www.frontiersin.org/articles/10.3389/fimmu.2026.1936690/full},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Immunological and metabolic profiles associated with active Giardia intestinalis infection in adults with metabolic disorders: an exploratory analysis
AU  - Sylwia Klimczak
AU  - Kacper Packi
AU  - Alicja Rudek
AU  - Sylwia Wenclewska
AU  - Marcin Kurowski
AU  - Agnieszka Śliwińska
PY  - 2026
DA  - 2026/10/27
JO  - Frontiers in Immunology
DO  - 10.3389/fimmu.2026.1936690
UR  - https://www.frontiersin.org/articles/10.3389/fimmu.2026.1936690/full
AB  - Background: Giardiasis may present with nonspecific gastrointestinal symptoms, and conventional diagnostic approaches may not fully capture host-response differences in clinically complex patients. This study characterized immunological and metabolic measurements associated with active G. intestinalis infection in adults with metabolic disorders and examined their differences according to infection status and treatment stage. An exploratory secondary analysis assessed whether selected variables could jointly discriminate infection status.  Methods: In this prospective observational study, 84 adults with metabolic disorders aged 40–65 years were included at baseline and classified according to G. intestinalis infection status; 80 participants were included in the final analytical sample. Anti- Giardia IgM and IgG, multiplex cytokines, chemokines and growth factors, anthropometric measures, and metabolic parameters were assessed. Differences according to infection status and treatment stage were examined using non-parametric tests, Spearman correlations, and logistic regression. Selected variables were subsequently evaluated using multivariable logistic regression and receiver operating characteristic (ROC) analysis. Internal model performance was assessed using bootstrap resampling and stratified 10-fold cross-validation within the study cohort.  Results: Active G. intestinalis infection was associated with lower glucose, BMI, and HOMA-IR values and with differences in selected inflammatory mediators. IgM, IL-12p40, IL-8, RANTES, and IL-2R were among the variables associated with infection status in regression analyses. An exploratory integrated model including glucose, BMI, IgM, RANTES, IL-12p40, and IL-2R showed an apparent AUC of 0.953. Internal performance assessment using bootstrap resampling and stratified 10-fold cross-validation yielded similar estimates within the study cohort. Differences in apparent AUC between the integrated, immunological, and metabolic models were interpreted descriptively because no formal statistical comparison of ROC curves was performed.  Conclusions: In this study population, active G. intestinalis infection was associated with distinct immunological and metabolic patterns. The exploratory multivariable analysis identified a combination of immunological and metabolic variables with high apparent discriminatory performance within the present cohort. These findings are hypothesis-generating, and the identified predictor combination requires evaluation in substantially larger independent cohorts with prospective model development and external validation before its predictive or clinical utility can be determined.
SN  - 1664-3224
ER  -